Claybrook Capital’s Encompass Health EHC Stock Holding History

Claybrook Capital’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-151	Closed	-$7K	–	253
2018 Q4	$7K	Buy	+151	New	+$8.59K	﹤0.01%	528

Other funds holding EHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Claybrook Capital's EHC Position: Q1 2019 in Review

Claybrook Capital sold out of Encompass Health (EHC) in Q1 2019, closing a stake of 151 shares — an estimated $7K sold.

Claybrook Capital first reported a position in EHC in Q4 2018 and held it in 1 quarter. The position peaked at $7K in Q4 2018. 427 funds tracked by Wall St. Rank hold EHC as of Q1 2019.

Claybrook Capital reported no remaining Encompass Health position as of Q1 2019 after selling out during the quarter.
Claybrook Capital sold 151 Encompass Health shares in Q1 2019, an estimated $7K.
Claybrook Capital first reported a position in Encompass Health in Q4 2018 and held it in 1 quarter.
Claybrook Capital's Encompass Health position peaked at $7K in Q4 2018.
427 funds tracked by Wall St. Rank held Encompass Health as of Q1 2019.

Based on Claybrook Capital's 13F filing for Q1 2019, filed 15 May 2019.